A 34-year old female patient presented by a left breast malignant
Download scientific diagram | A 34-year old female patient presented by a left breast malignant mass (black arrows) and enlarged axillary lymph nodes (T2N2M0) treated by chemotherapy. Conventional mammogram (A) and (B) MLO and CC views and (C) contrast mammogram MLO view. Post treatment views conventional mammogram (D) and (E) MLO and CC views and (F) contrast mammogram MLO view. Follow-up after treatment revealed nearly total resolution in the mass size with no significant enhancement and LNs became smaller in size (white arrows) and staging became T0N1M0 denoting minimal residual disease (I). from publication: Role of contrast enhanced spectral mammography in predicting pathological response of locally advanced breast cancer post neo-adjuvant chemotherapy | Objective: To evaluate the accuracy of CESM technique in predicting the final pathological response and residual tumor size post NAC in LABC. Patients and methods: This study was prospectively carried on 21 female patients diagnosed with stage II and III breast cancer. CESM | Mammography, Drug Therapy and Breast Cancer | ResearchGate, the professional network for scientists.
Breast Cancer Ultrasonography: Practice Essentials, Role of Ultrasonography in Screening, Breast Imaging Reporting and Data System
Cancer Survival Rates Are Improving, Researchers Say
Extensive” T4 breast tumors: Considerations regarding local management. –
Breast Cancer: Symptoms, Types, Causes & Treatment
Role of contrast enhanced spectral mammography in predicting pathological response of locally advanced breast cancer post neo-adjuvant chemotherapy - ScienceDirect
Medicina, Free Full-Text
Eman EL DESOUKY, Professor (Associate), National Cancer Institute Egypt, Cairo, NCI, Department of Epidemiology and Biostatistics
Mom's late cancer diagnosis highlights health-care challenges Black women face, expert says
PHOTO GALLERY: What does breast cancer look like on mammography
Cost-effective, portable, patient-dedicated three-dimensional automated breast ultrasound for point-of-care breast cancer screening
case 1): A female patient 47year-old underwent left MRM, received
Cureus, Bilateral Concurrent Benign Phyllodes Tumor in a 43-Year-Old Female: A Case Report
PDF) Role of contrast enhanced spectral mammography in predicting pathological response of locally advanced breast cancer post neo-adjuvant chemotherapy
Eman EL DESOUKY, Professor (Associate), National Cancer Institute Egypt, Cairo, NCI, Department of Epidemiology and Biostatistics
New treatment helps New Brunswick breast cancer patient keep her hair